GlassScriptPhysician profile
David B Schwartz
NPI 1215903737
$169,388.11
in general payments reported to CMS, 2019-2025
34 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $108K · 2020: $15K · 2021: $13K · 2022: $27K · 2023: $6,330 · 2024: $79.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,600 · Food and Beverage: $1,738 · Travel and Lodging: $992 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,600.00 |
| Food and Beverage | $1,738.44 |
| Travel and Lodging | $991.85 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $53,593.70 | 2019-2021 | |
| Abbvie INC. | $42,164.68 | 2019-2023 | Liletta, Orilissa, Lo Loestrin Fe |
| Gynesonics, INC. | $31,683.20 | 2021-2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Duchesnay USA Incorporated | $15,440.51 | 2019 | |
| Coopersurgical, INC. | $12,323.13 | 2020-2022 | |
| Hologic Sales and Service, LLC | $10,126.08 | 2019-2022 | |
| Astellas Pharma US INC | $609.53 | 2021-2024 | Veozah, Myrbetriq |
| Therapeuticsmd, INC. | $578.51 | 2019-2022 | |
| Caldera Medical, INC | $447.07 | 2021 | |
| Ethicon Endo-Surgery INC. | $400.00 | 2020 | |
| Sumitomo Pharma America, INC. | $297.20 | 2023 | Myfembree |
| Minerva Surgical, INC | $248.52 | 2020-2022 | |
| Baxter Healthcare | $235.14 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $220.47 | 2021-2023 | |
| Pfizer INC. | $176.09 | 2019-2023 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Channel Medsystems, INC. | $159.14 | 2022 | |
| Conmed Corporation | $148.49 | 2019 | |
| Exeltis, USA INC. | $122.11 | 2021-2023 | Solosec |
| Shield Therapeutics INC | $65.28 | 2023 | Accrufer |
| Boston Scientific Corporation | $47.73 | 2019-2021 | |
| Amgen INC. | $45.38 | 2019-2021 | |
| Exact Sciences Corporation | $43.32 | 2023 | Cologuard Collection Kit |
| Amag Pharmaceuticals, INC. | $43.32 | 2019 | |
| Convatec INC. | $22.33 | 2019 | |
| Myovant Sciences INC. | $21.58 | 2022 | |
| Teleflex LLC | $18.57 | 2021 | |
| Avion Pharmaceuticals | $15.66 | 2022 | |
| Mallinckrodt Enterprises LLC | $13.49 | 2019 | |
| Daiichi Sankyo INC. | $13.49 | 2021 | |
| Mycovia Pharmaceuticals, INC. | $13.31 | 2022 | |
| Allergan, INC. | $13.06 | 2019 | |
| Axonics, INC. | $12.96 | 2022 | |
| Gilead Sciences, INC. | $12.73 | 2019 | |
| Vertical Pharmaceuticals, LLC | $12.33 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Schwartz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.